New Insights into a Unique Amyloid Fold Linked to a Rare Alzheimer's Variant
Alzheimer's disease presents significant challenges for researchers due to its complexity and variability among patients. A particularly rare variant of Alzheimer's has been identified, occurring in only two families and two other individuals, which is caused by a mutation in the Flemish amyloid-beta precursor protein (APP). This genetic anomaly affects the accumulation of amyloid-beta (Aβ) protein plaques in the brain, leading to a condition known as cerebral amyloid angiopathy (CAA). CAA is associated with brain hemorrhages and often results in death by the late 50s. An international research team has recently published their findings in Nature Structural & Molecular Biology, revealing how the Aβ filaments fold uniquely in individuals with this type of Alzheimer's. The researchers utilized postmortem brain tissue samples from two individuals, each from the affected Flemish families, to study the structural characteristics of the amyloid fold. Through advanced imaging techniques, specifically cryogenic electron microscopy (cryo-EM), they discovered a novel Z-shaped fold that had not been observed before. This unique configuration is significant because it exposes a specific amino acid, the F20 residue, which likely facilitates interactions with blood vessel walls. The mutation responsible for this fold removes a single methyl group from the Aβ protein, promoting the formation of this specific fold. The research indicates that although the Aβ proteins produced by this mutation are less likely to aggregate in vitro, they can still cause substantial neurotoxic effects, similar to those seen with the more common forms of Alzheimer's. The findings highlight the importance of understanding the structural characteristics of amyloid proteins, as they are crucial for developing effective treatments for various forms of Alzheimer's disease. Future research aims to explore how this newly identified fold contributes to brain damage and the biological mechanisms involved, as well as its implications for other hereditary and sporadic forms of Alzheimer's disease. The study underscores the need for continued investigation into the diverse manifestations of Alzheimer's and the potential for targeted therapeutic strategies.




